We are live on
!
Find out more
DA
Dillon & Associates Portfolio holdings
AUM
$726M
1-Year Est. Return
18.59%
This Fund
S&P 500
This Quarter
Est. Return
+13.81%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$461M
AUM Growth
+$46M
(+11%)
Cap. Flow
-$3.97M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
49.86%
Holding
68
New
1
Increased
15
Reduced
38
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Tower
AMT
|
+$443K |
| 2 |
Salesforce
CRM
|
+$389K |
| 3 |
NVO
Novo Nordisk
NVO
|
+$301K |
| 4 |
Comcast
CMCSA
|
+$280K |
| 5 |
O'Reilly Automotive
ORLY
|
+$208K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.52M |
| 2 |
Becton Dickinson
BDX
|
+$440K |
| 3 |
Colgate-Palmolive
CL
|
+$349K |
| 4 |
Visa
V
|
+$343K |
| 5 |
Abbott
ABT
|
+$310K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.28% |
| 2 | Healthcare | 18.15% |
| 3 | Communication Services | 11.41% |
| 4 | Financials | 11.06% |
| 5 | Consumer Discretionary | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
51
DELISTED
Kellanova
K
| $524K | 0.11% |
9,008
| – | – |
|
52
Target
TGT
$65.6B
| $503K | 0.11% |
2,840
| – | – |
|
53
Eaton
ETN
$161B
| $437K | 0.09% |
3,643
| – | – |
|
54
NeoGenomics
NEO
$1.96B
| $432K | 0.09% |
8,000
| – | – |
|
55
UnitedHealth
UNH
$376B
| $408K | 0.09% |
1,161
| – | – |
|
56
Bristol-Myers Squibb
BMY
$133B
| $351K | 0.08% |
5,658
+51
| +0.9% | +$3.14K |
|
57
Cisco
CSCO
$457B
| $349K | 0.08% |
7,755
-400
| -5% | -$16.4K |
|
58
Chipotle Mexican Grill
CMG
$47.2B
| $327K | 0.07% |
11,800
+150
| +1% | +$3.94K |
|
59
Emerson Electric
EMR
$83.9B
| $313K | 0.07% |
3,907
| – | – |
|
|
60
Comcast
CMCSA
$85B
| $304K | 0.07% |
+5,850
| New | +$280K |
|
61
Coca-Cola
KO
$377B
| $302K | 0.07% |
5,484
| – | – |
|
62
United Parcel Service
UPS
$88.6B
| $238K | 0.05% |
1,417
| – | – |
|
|
WBA
63
DELISTED
Walgreens Boots Alliance
WBA
| $221K | 0.05% |
5,516
-825
| -13% | -$32K |
|
64
Huntington Bancshares
HBAN
$34.4B
| $164K | 0.04% |
12,617
-275
| -2% | -$3.13K |
|
65
Imunon
IMNN
$6.68M
| $16K | ﹤0.01% |
114
| – | – |
|
66
Rockwell Medical
RMTI
$28.4M
| $11K | ﹤0.01% |
104
| – | – |
|
67
Biogen
BIIB
$30B
| – | – |
-1,031
| Closed | -$293K |
|
68
Berkshire Hathaway Class B
BRK.B
$1.1T
| – | – |
-1,086
| Closed | -$231K |
|
Similar funds
TC
F
SDH
SCM
MWP
FAN
TFHU
AGAM
Dillon & Associates's Q4 2020 Portfolio in Review
As of Q4 2020, Dillon & Associates held 68 positions worth $461M, up 11% from $415M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Trading was light in Q4 2020: portfolio turnover was 4.4%. Dillon & Associates opened 1 new position and exited 2, leaving the 68-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Communication Services.
- Dillon & Associates's largest Q4 2020 buy was Comcast: 5,850 shares worth $304K.
- Dillon & Associates added most to American Tower in Q4 2020, an estimated $443K increase.
- Dillon & Associates's biggest Q4 2020 reduction was Apple, cutting an estimated $1.52M.
- Dillon & Associates fully exited Biogen in Q4 2020, selling an estimated $293K.
- Dillon & Associates's ten largest holdings make up 50% of its $461M portfolio in Q4 2020.
- Dillon & Associates opened 1 new position and closed 2 in Q4 2020.
- Dillon & Associates's portfolio value rose 11% quarter-over-quarter to $461M.
Based on Dillon & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.